Terms: = Pancreatic cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Diagnosis
15 results:
1. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
2. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.
He Z; Wang J; Zhu C; Xu J; Chen P; Jiang X; Chen Y; Jiang J; Sun C
Cancer Lett; 2022 Nov; 548():215751. PubMed ID: 35718269
[TBL] [Abstract] [Full Text] [Related]
3. Increased Nuclear Transporter KPNA2 Contributes to Tumor Immune Evasion by Enhancing PD-L1 Expression in PDAC.
Zhou KX; Huang S; Hu LP; Zhang XL; Qin WT; Zhang YL; Yao LL; Yu Y; Zhou YQ; Zhu L; Ji J; Zhang ZG
J Immunol Res; 2021; 2021():6694392. PubMed ID: 33728352
[TBL] [Abstract] [Full Text] [Related]
4. MiR-337 suppresses pancreatic cancer development via stat3/Wnt/β-catenin axis.
Shi J; Su Q; Han F; Chen W; Zhang D; Xu B
Anticancer Drugs; 2021 Aug; 32(7):681-692. PubMed ID: 33587353
[TBL] [Abstract] [Full Text] [Related]
5. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers.
Alizadeh A; Jebelli A; Baradaran B; Amini M; Oroojalian F; Hashemzaei M; Mokhtarzadeh A; Hamblin MR
Gene; 2021 Feb; 769():145224. PubMed ID: 33059027
[TBL] [Abstract] [Full Text] [Related]
6. Extensive protein S-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis.
Tan C; Li Y; Huang X; Wei M; Huang Y; Tang Z; Huang H; Zhou W; Wang Y; Hu J
Cell Death Dis; 2019 Dec; 10(12):914. PubMed ID: 31801946
[TBL] [Abstract] [Full Text] [Related]
7. Significance of IL28RA in diagnosis of early pancreatic cancer and its regulation to pancreatic cancer cells by JAK/STAT signaling pathway - effects of IL28RA on pancreatic cancer.
Yang L; Wei WC; Meng XN; Gao J; Guo N; Wu FT; Zeng WW
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9863-9870. PubMed ID: 31799654
[TBL] [Abstract] [Full Text] [Related]
8. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by stat3.
Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
[TBL] [Abstract] [Full Text] [Related]
9. Mahanimbine Exerts Anticancer Effects on Human pancreatic cancer Cells by Triggering Cell Cycle Arrest, Apoptosis, and Modulation of AKT/Mammalian Target of Rapamycin (mTOR) and Signal Transducer and Activator of Transcription 3 (stat3) Signalling Pathways.
Pei C; He Q; Liang S; Gong X
Med Sci Monit; 2018 Oct; 24():6975-6983. PubMed ID: 30273298
[TBL] [Abstract] [Full Text] [Related]
10. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.
Fan K; Yang C; Fan Z; Huang Q; Zhang Y; Cheng H; Jin K; Lu Y; Wang Z; Luo G; Yu X; Liu C
Cancer Lett; 2018 Apr; 418():167-175. PubMed ID: 29337110
[TBL] [Abstract] [Full Text] [Related]
11. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
Huang L; Ma B; Ma J; Wang F
Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
[TBL] [Abstract] [Full Text] [Related]
12. Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in pancreatic cancer.
Smigiel JM; Parameswaran N; Jackson MW
Mol Cancer Res; 2017 Apr; 15(4):478-488. PubMed ID: 28053127
[TBL] [Abstract] [Full Text] [Related]
13. Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae.
Aravindan S; Delma CR; Thirugnanasambandan SS; Herman TS; Aravindan N
PLoS One; 2013; 8(4):e61977. PubMed ID: 23613993
[TBL] [Abstract] [Full Text] [Related]
14. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia.
Kang R; Loux T; Tang D; Schapiro NE; Vernon P; Livesey KM; Krasinskas A; Lotze MT; Zeh HJ
Proc Natl Acad Sci U S A; 2012 May; 109(18):7031-6. PubMed ID: 22509024
[TBL] [Abstract] [Full Text] [Related]
15. Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3.
Bharadwaj U; Li M; Chen C; Yao Q
Mol Cancer Res; 2008 Nov; 6(11):1755-65. PubMed ID: 19010822
[TBL] [Abstract] [Full Text] [Related]
